Activity

Among eleven patients, the mean preoperative logMAR BCVA was 0.2 (SD 0.13; range 0-0.5), representing a Snellen VA of 20/63. The mean postoperative logMAR BCVA was 1.0 (SD 0.24; range 0.5-1.3), corresponding to a Snellen VA of 20/10. Postoperative visual impairment began roughly 12 weeks after the procedure (standard deviation 62; range 3-20), specifically characterized by a loss of 8 lines of vision (standard deviation 23; range -11 to -4). The removal of SO, on average, occurred 139 days following the initial ppV, exhibiting a standard deviation of 500 days and a range of 88 to 271 days. During the in-situ period of the subject, visual decline occurred in nine instances. Two weeks after the surgical procedure to remove the SO, the BCVA of two patients showed a decline. A preoperative central foveal thickness (CFT) of 254µm (standard deviation 242µm) was observed in all cases, decreasing to 224µm (standard deviation 296µm) during sub-Tenon (SO) tamponade and rising to 247µm (standard deviation 292µm) after SO removal, independent of the presence or absence of UVL procedures. Patients’ average time of observation post-obstruction removal was 20 months, exhibiting a standard deviation of 306 months.

The frequency of UVL after SO tamponade in cases of macula-on RRD exceeds expectations. A 50% incidence was observed across our case series. The secret behind this phenomenon continues to elude our understanding. Generally, vitreoretinal specialists should meticulously examine the justification for SO tamponade, educate their patients about potential UVL procedures, and promptly extract SO whenever feasible.

With the ethical approval of the Ethikkommission der Universitat Regensburg (Votum 22-2925-104) on May 6th, 2022, the study proceeded, adhering to the ethical principles within the Declaration of Helsinki.

The study was carried out in line with the ethical standards set forth in the Declaration of Helsinki, having received approval from the local ethics committee on May 6, 2022 (Ethikkommission der Universitat Regensburg, Votum 22-2925-104).

A significant clinical issue arises from carbapenem-resistant Klebsiella pneumoniae (CRKP), compounded by the paucity of therapeutic alternatives. During the last ten years, CRKP strains have progressively become a pervasive and essential healthcare concern across the world. The pervasive global expansion of CRKP has made it a significant threat to public well-being. We are compelled to examine novel therapeutic methods. Infections involving bacteria resistant to multiple drugs find bacteriophages to be a potent and restorative solution. Bacteriophages present a hopeful avenue for addressing CRKP infections.

Through the isolation, characterization, and sequencing of the novel K. pneumoniae phage, vB_KshKPC-M, this study revealed its capability to specifically target and lyse Carbapenem-resistant K. pneumoniae.

One hundred clinical isolates of Klebsiella pneumoniae were obtained from COVID-19 patients experiencing ventilator-associated acute pneumonia at Shahid Beheshti Hospital in Kashan, Iran, between 2020 and 2021. After all samples were cultured initially, conventional biochemical tests were used for the identification of bacterial isolates. The isolates were subsequently confirmed through PCR using the ureD gene. Minimum inhibitory concentration testing for colistin, alongside the disc diffusion technique for antibiotic susceptibility determination, was undertaken and interpreted in accordance with the guidelines. Phenotypic and molecular methods were instrumental in elucidating the carbapenem resistance exhibited by the isolates. The amplification of the blaKPC, blaNDM, and blaOXA-23 genes was crucial for this detection process. A quantitative microtiter plate (MTP) approach was employed for the determination of biofilm in CRKP isolates. Samples of wastewater collected during the summer at a specified location within Beheshti Hospital (Kashan, Iran) were used to isolate the phage. Against a bacterial host, a CRKP strain isolated from a COVID-19 pneumonia patient displaying colistin resistance and robust biofilm production capabilities, the sample was processed and purified. Referring to the isolate, it is known as Kp100. The separated phages were diluted and a titration was performed using the double overlay agar plaque assay. Utilizing a 10% PEG solution, the separate phage is concentrated and stored at -80°C until required. The spot test method yielded the identification of the phage host range. The morphology of the purified phage was ascertained using a transmission electron microscope. The pH and temperature phage stability tests were subjected to analysis. We investigated how cationic ions influenced phage adsorption. The optimal bacteriophage concentration was established to diminish the CRKP strain. The latent period and size of the purified phage burst were investigated by employing one-step growth assays. SDS-PAGE was utilized in the examination of phage proteins. Via the chloroform extraction technique, phage DNA was obtained, and the entire genome of the lytic phage was subsequently sequenced using the Illumina HiSeq platform (Illumina, San Diego, CA, USA). Geneious Prime 20212.2 and Spades 39.0 were used for preprocessing tasks, like trimming, to uphold quality standards. CH5126766 The lytic phage’s full genome sequence is associated with a particular entry in the GenBank database, designated by its accession number. The RASTtk-v1073 tool was employed to predict and annotate the open reading frames (ORFs). Prediction of open reading frames was executed with PHASTER software. ResFinder is a tool used to determine whether antimicrobial resistance and virulence genes are present in a genome. The tRNAs can-SE v20.6 tool serves to detect and identify tRNA sequences in a genome. Genome comparisons of linear phages and the visualization of their coding regions were undertaken using the tools Easyfig 22.3 and Mauve 24.0. The PHACTS program provided a prediction of the lifestyles pursued by phages. An analysis of phage core proteins’ phylogenies and amino acid sequences, including the major capsid protein, was conducted. Reconstructions of phylogenies were performed employing the Neighbor-Joining method, validated by 1000 bootstrap repetitions. The depolymerase was predicted using the HHpred software tool. The statistical analysis of this study relied on GraphPad Prism version 9.1. The sets and the control sets were compared utilizing a student’s t-test, and the significance level was established as P=0.005.

Within the systematic classification, phage vB_KshKPC-M is assigned to the Siphoviridae family, a part of the order Caudovirales. A linear double-stranded DNA phage of 54,378 base pairs was observed, characterized by a 50.08% G+C content. It exhibited a relatively wide host range (97.7%), a short latency period of 20 minutes, and a notable burst size of 260 PFU/cell. Stability was maintained at varying pH values (3-11) and temperatures (45-65°C). Within the vB KshKPC-M genome, there are 91 open-reading frames. The phage genome lacks tRNA genes, genes responsible for antibiotic resistance, toxic components, virulence-related genes, and clusters of genes involved in lysogeny. Comparative genomics revealed a sequence homology between phage vB_KshKPC-M and various Klebsiella phages, including phage 13 (NC 0498441), phage Sushi (NC 0287741), phage vB_KpnD PeteCarol (OL5394481), and phage PWKp14 (MZ6343451).

Its impressive ability to affect a wide variety of hosts, in addition to its antibacterial action, makes it a promising candidate for future phage therapy applications. The antibiotic-resistant clinical isolates were mostly lysed by the isolated phage. Therefore, the phage can be used either as a single agent or as part of a phage cocktail in future studies to control and inhibit respiratory infections caused by these bacterial species, especially in treating respiratory infections stemming from resistant bacterial strains in patients.

Given its broad host range and potent antibacterial action, this entity holds significant promise for future phage therapy applications. The isolated phage effectively disrupted the cell walls of most antibiotic-resistant clinical isolates. Consequently, this bacteriophage can be utilized either in isolation or in a phage blend in future studies to control and impede respiratory infections originating from these bacteria, specifically in the remediation of respiratory infections due to resistant strains in unwell patients.

The composition of breast milk (BM) changes dynamically within women and differs significantly between women. The maternal dietary habits are expected to partially account for the discrepancies in the BM composition. A study was designed to assess the food quality score (FQS) in lactating mothers and explore its link with the indicators of breast milk quality and the antioxidant content of their babies’ urine samples.

The cross-sectional study comprised a sample of 350 lactating women, aged 20 to 35 years. Dietary intake data was gathered via a validated food frequency questionnaire (FFQ) with 65 food items. The FQS calculation involved aggregating the scores associated with healthy and unhealthy food groupings. Using FQS adherence as a criterion, subjects were grouped, with the subjects demonstrating the most FQS adherence in the third tertile and the subjects with the least FQS adherence being assigned to the first tertile. The Ferric reducing antioxidant power (FRAP), 2, 2′-diphenyl-1-picrylhydrazyl (DPPH), thiobarbituric acid reactive substances (TBARs), and Ellman’s assay protocols were applied to measure the antioxidant activity in BM and infant urine samples. The total BM protein, calcium, and triglyceride content was ascertained by utilizing standard biochemical kits.

Mothers in the third tertile of FQS exhibited BM with significantly elevated levels of DPPH, thiols, calcium, and protein compared to those in the lowest tertile (p<0.005).